Pascal Soriot has an awkward relationship with the UK. Now, the boss of AstraZeneca Plc is contemplating a megadeal with US peer Bristol-Myers Squibb Co. that could shift the British drugmaker’s center of gravity further westwards. It’s a potentially tricky tie-up. But Soriot’s counterintuitive bets
automated-news
FORM 8.3
automated-news
FORM 8.3
automated-news
Blackfin Joins Bevara Building Services: One Partner, One Invoice, One Self-Performing Relationship Across Multiple Markets.
automated-news
All about oncology? A cardio workout? Patent-cliff avoidance? American dreaming?
It’s a crisis for American governance when even the most seasoned and respected politicians feel free to vote their conscience only when they are on their way out. But that’s what’s happening with Senator John Cornyn’s late stand against President Donald Trump.
automated-news
Policy pledge comes as rightwing party drops behind Labour in polls
automated-news
Visa to acquire BioCatch for $2.4B, bolstering fraud detection capabilities
automated-news
Governments have stopped correcting budget deficits but — so far — bond markets have let them
Generals lose their current wars by fighting the last one. And regulators in the City of London and on the continent are creating a new crisis because they’re making exactly that mistake.